-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Bellicum Pharmaceuticals, Inc quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q1 2017 to Q3 2023.
- Bellicum Pharmaceuticals, Inc Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending September 30, 2023 was $1M, unchanged year-over-year.
- Bellicum Pharmaceuticals, Inc Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending September 30, 2023 was $1.51M.
- Bellicum Pharmaceuticals, Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $1.5M, a 75.8% decline from 2021.
- Bellicum Pharmaceuticals, Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $6.2M, a 1140% increase from 2020.
- Bellicum Pharmaceuticals, Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2020 was $500K, a 93% decline from 2019.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)